具有三方融合基因PML::RARG::LINE-L2a的非典型急性早幼粒细胞白血病对ATRA耐药，但对砷基治疗敏感。

IF 7.9 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-06-12 DOI:10.3324/haematol.2025.287318

Sanyun Wu, Yalan Yu, Xiang Lin, Xiaosu Zhou, Yuanyuan Zhou, Ping Luo, Hui Shen, Jing He, Li Liu, Xiaoyan Liu, Dong Lei Zhang, Yanan Liu, Hui Xiao, Fuling Zhou, Hongxing Liu, Zhanglin Zhang

引用次数: 0

摘要

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Atypical acute promyelocytic leukemia with tripartite fusion gene PML::RARG::LINE-L2a is resistant to ATRA but sensitive to arsenic-based therapy.

Not available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.